IFP - IAP Immunization Timetable
Age Vaccines Comments
Birth BCG
OPV 0
Hep-B 1
Administer Hep-B vaccine to all newborns before hospital discharge
6 weeks DTwP 1/DTaP 1
IPV 1
Hep-B 2
Hib 1
Rotavirus* 1
PCV 1
IPV: two doses instead of 3 can be used for primary series if started at 8 and 16 weeks Rotavirus vaccine: Only 2 doses of RV-1 and 3 doses of RV-5
10 weeks   Polio: Additional doses of OPV on all NIDs/SNIDs
14 weeks   Polio: Additional doses of OPV on all NIDs/SNIDs
Only 2 doses of RV1 are needed.
6 months   The final (third or fourth) dose in the HepB vaccine series should be administered no earlier than age 24 weeks and at least 16 weeks after the first dose.
9 months
12 months Hepatitis A: For both killed and live hepatitis-A vaccines, 2 doses are recommended
15 months The risk of breakthrough varicella is lower if given 15 months onwards.
16 to 18 months The first booster (4thth dose) may be administered as early as age 12 months, provided at least 6 months have elapsed since the third dose.
18 months 2 doses of both killed and live hepatitis-A vaccines
2 years Typhoid revaccination every 3 years, if Vi-polysaccharide vaccine is used.
5 years MMR: the 2nd dose can be given at anytime 4-8 weeks after the 1st dose.
Varicella: the 2nd dose can be given at anytime 3 months after the 1st dose.
10 to 12 years Tdap: is preferred to Td followed by Td every 10 years. HPV: Only for females, 3 doses at 0, 1-2 (depending on brands) and 6 months.
IAP recommended vaccines for High-risk* children (Vaccines under special circumstances):
  • Influenza Vaccine
  • Meningococcal Vaccine
  • Japanese Encephalitis Vaccine
  • Cholera Vaccine
  • Rabies Vaccine
  • Yellow Fever Vaccine
  • Pneumococcal Polysaccharide vaccine (PPSV 23)
* High-risk category of children:
  • Congenital or acquired immunodeficiency (including HIV infection), 
  • Chronic cardiac, pulmonary (including asthma if treated with prolonged high-dose oral corticosteroids), hematologic, renal (including nephrotic syndrome), liver disease and diabetes mellitus
  • Children on long term steroids, salicylates, immunosuppressive or radiation therapy
  • Diabetes mellitus, Cerebrospinal fluid leak, Cochlear implant, Malignancies,
  • Children with functional/ anatomic asplenia/ hyposplenia
  • During disease outbreaks
  • Laboratory personnel and healthcare workers
  • Travelers